510(k) K892380— DADE(R) IMMUNOASSAY CONTROLS, LEVELS I, II, III

Substantially Equivalent

Baxter Healthcare Corp

Clearance details

Applicant: Baxter Healthcare Corp
Product code: Code DIF
Advisory panel: Clinical Toxicology
Date received: 1989-04-06
Decision date: 1990-02-08
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Miami, FL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.